The digitalis-like steroid hormones: New mechanisms of action and biological significance

Life Sciences

Volumn 80, Issue 23, 2007, Pages 2093-2107

  Nesher, Maoz ^a   Shpolansky, Uri ^a   Rosen, Haim ^a   Lichtstein, David ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Digitalis; K+ ATPase; Na+; Natriuretic hormone; Ouabain; Steroids

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CARDIAC GLYCOSIDE; DIGITALIS; STEROID HORMONE;

ADRENAL GLAND; APOPTOSIS; BLOOD PRESSURE REGULATION; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; DEPRESSION; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART RHYTHM; HORMONE BINDING; HORMONE RELEASE; HORMONE STRUCTURE; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; ION TRANSPORT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BIOLOGICAL TRANSPORT; DIGITALIS; ENDOCYTOSIS; HUMANS; IONS; MODELS, BIOLOGICAL; NA(+)-K(+)-EXCHANGING ATPASE; NATRIURETIC AGENTS; OUABAIN; PLANT EXTRACTS; POTASSIUM; SODIUM; STEROIDS;

STROPHANTHUS GRATUS;

EID: 34248570330     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.03.013     Document Type: Review

References (205)

1. Abramowitz J., Dai C., Hirschi K.K., Dmitrieva R.I., Doris P.A., Liu L., and Allen J.C. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5. Circulation 108 24 (2003) 3048-3053
2. Aizman O., Uhlen P., Lal M., Brismar H., and Aperia A. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proceedings of the National Academy of Sciences of the United States of America 98 23 (2001) 13420-13424
3. +]i-independent death signaling triggered by cardiotonic steroids. Pathophysiology 12 2 (2005) 125-135
4. Antolovic R., Kost H., Linder D., Linder M., Thonges D., Lichtstein D., and Schoner W. Demonstration of a specific transport protein for cardiac glycosides in bovine blood. Annals of the New York Academy of Sciences 834 (1997) 618-620
5. (+). American Journal of Physiology. Heart and Circulatory Physiology 279 2 (2000) H679-H691
6. Avila J., Lecuona E., Morales M., Soriano A., Alonso T., and Martin-Vasallo P. Opposite expression pattern of the human Na,K-ATPase beta 1 isoform in stomach and colon adenocarcinomas. Annals of the New York Academy of Sciences 834 (1997) 653-655
7. Aydemir-Koksoy A., Abramowitz J., and Allen J.C. Ouabain-induced signaling and vascular smooth muscle cell proliferation. The Journal of Biological Chemistry 276 49 (2001) 46605-46611
8. Bagrov A.Y., and Fedorova O.V. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension. Frontiers in Bioscience 10 (2005) 2250-2256
9. +-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31 5 (1998) 1097-1103
10. Bagrov Y.Y., Manusova N.B., Egorova I.A., Fedorova O.V., and Bagrov A.Y. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Frontiers in Bioscience 10 (2005) 2257-2262
11. Banerjee S.P., Bosmann H.B., and Morgan H.R. Oncogenic transformation of chick-embryo fibroblasts by Rous sarcoma virus alters rubidium uptake and ouabain binding. Experimental Cell Research 104 1 (1977) 111-117
12. Bauer N., Muller-Ehmsen J., Kramer U., Hambarchian N., Zobel C., Schwinger R.H., Neu H., Kirch U., Grunbaum E.G., and Schoner W. Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of beta-blockade and angiotensin-converting enzyme inhibition. Hypertension 45 5 (2005) 1024-1028
13. Beguin P., Wang X., Firsov D., Puoti A., Claeys D., Horisberger J.D., and Geering K. The gamma subunit is a specific component of the Na,K-ATPase and modulates its transport function. The EMBO Journal 16 14 (1997) 4250-4260
14. Blanco G., and Mercer R.W. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. The American Journal of Physiology 275 5 Pt 2 (1998) F633-F650
15. Blaustein M.P., Zhang J., Chen L., and Hamilton B.P. How does salt retention raise blood pressure. American Journal of Physiology. Heart and Circulatory Physiology 290 3 (2006) R514-R523
16. Breitwieser G.E. Calcium sensing receptors and calcium oscillations: calcium as a first messenger. Current Topics in Developmental Biology 73 (2006) 85-114
17. Buckalew V.M. Endogenous digitalis-like factors. An historical overview. Frontiers in Bioscience 10 (2005) 2325-2334
18. Budzikowski A.S., Huang B.S., and Leenen F.H. Brain "ouabain", a neurosteroid, mediates sympathetic hyperactivity in salt-sensitive hypertension. Clinical and Experimental Hypertension 20 2 (1998) 119-140
19. (+)-ATPase. The American Journal of Physiology 269 5 Pt 2 (1995) F637-F643
20. (+)-ATPase is associated with endocytosis of its alpha- and beta-subunits. The American Journal of Physiology 273 5 Pt 1 (1997) C1458-C1465
21. Chow D.C., and Forte J.G. Functional significance of the beta-subunit for heterodimeric P-type ATPases. The Journal of Experimental Biology 198 Pt 1 (1995) 1-17
22. Christo P.J., and el-Mallakh R.S. Possible role of endogenous ouabain-like compounds in the pathophysiology of bipolar illness. Medical Hypotheses 41 4 (1993) 378-383
23. Chuang D.M., Hough C., and Senatorov V.V. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annual Review of Pharmacology and Toxicology 45 (2005) 269-290
24. Chueh S.C., Guh J.H., Chen J., Lai M.K., and Teng C.M. Dual effects of ouabain on the regulation of proliferation and apoptosis in human prostatic smooth muscle cells. The Journal of Urology 166 1 (2001) 347-353
25. Colonna T.E., Huynh L., and Fambrough D.M. Subunit interactions in the Na,K-ATPase explored with the yeast two-hybrid system. The Journal of Biological Chemistry 272 19 (1997) 12366-12372
26. (+)-ATPase and cell attachment. Journal of Cell Science 112 Pt 23 (1999) 4223-4232
27. +-ATPase relaxes cell attachment and sends a specific signal (NACos) to the nucleus. The Journal of Membrane Biology 198 3 (2004) 147-158
28. +-ATPase inhibitor from rat brain. The American Journal of Physiology 254 6 Pt 2 (1988) F912-F917
29. Crambert G., Hasler U., Beggah A.T., Yu C., Modyanov N.N., Horisberger J.D., Lelievre L., and Geering K. Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. The Journal of Biological Chemistry 275 3 (2000) 1976-1986
30. Daniel D., Susal C., Kopp B., Opelz G., and Terness P. Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives. International Immunopharmacology 3 13-14 (2003) 1791-1801
31. (+)-ATPase from midbrain and adrenal. The American Journal of Physiology 274 1 Pt 2 (1998) F182-F188
32. De Wardener H.E. The natriuretic hormone. Proceedings of the European Dialysis and Transplant Association 10 (1973) 3-19
33. De Wardener H.E. The hypothalamus and hypertension. Physiological Reviews 81 4 (2001) 1599-1658
34. Delamere N.A., and Tamiya S. Expression, regulation and function of Na,K-ATPase in the lens. Progress in Retinal and Eye Research 23 6 (2004) 593-615
35. Devarajan P., Scaramuzzino D.A., and Morrow J.S. Ankyrin binds to two distinct cytoplasmic domains of Na,K-ATPase alpha subunit. Proceedings of the National Academy of Sciences of the United States of America 91 8 (1994) 2965-2969
36. Dmitrieva R.I., and Doris P.A. Ouabain is a potent promoter of growth and activator of ERK1/2 in ouabain-resistant rat renal epithelial cells. The Journal of Biological Chemistry 278 30 (2003) 28160-28166
37. Dolmetsch R.E., Xu K., and Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392 6679 (1998) 933-936
38. Don B., Schambelan M., and Lo J.C. Endocrine hypertension. In: Greenspan F.C., and Gardner D.G. (Eds). Endocrine Hypertension (2004), Lange Medical Books/McGraw-Hill, NY 100-120
39. +-ATPase alpha-subunit is essential for AP-2 binding and clathrin-dependent endocytosis. The Journal of Biological Chemistry 277 19 (2002) 17108-17111
40. Doris P.A., Jenkins L.A., and Stocco D.M. Is ouabain an authentic endogenous mammalian substance derived from the adrenal?. Hypertension 23 5 (1994) 632-638
41. Dostanic-Larson I., Van Huysse J.W., Lorenz J.N., and Lingrel J.B. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proceedings of the National Academy of Sciences of the United States of America 102 44 (2005) 15845-15850
42. +-ATPase and biological significance of their cardiac glycoside binding site. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 290 3 (2006) R524-R528
43. Dostanic I., Paul R.J., Lorenz J.N., Theriault S., Van Huysse J.W., and Lingrel J.B. The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. American Journal of Physiology. Heart and Circulatory Physiology 288 2 (2005) H477-H485
44. (+)-ATPase molecules to the plasma membrane. Biochemistry 39 32 (2000) 9884-9892
45. +-ATPase {alpha}1-subunit phosphorylation signal into binding and activation of phosphoinositide 3-kinase during endocytosis. The Journal of biological chemistry 280 16 (2005) 16272-16277
46. Elkareh J., Kennedy D.J., Yashaswi B., Vetteth S., Shidyak A., Kim E.G., Smaili S., Periyasamy S.M., Hariri I.M., Fedorova L., Liu J., Wu L., Kahaleh M.B., Xie Z., Malhotra D., Fedorova O.V., Kashkin V.A., Bagrov A.Y., and Shapiro J.I. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 49 1 (2007) 215-224
47. Espineda C., Seligson D.B., James Ball Jr. W., Rao J., Palotie A., Horvath S., Huang Y., Shi T., and Rajasekaran A.K. Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 97 8 (2003) 1859-1868
48. Fedorova O.V., Anderson D.E., Lakatta E.G., and Bagrov A.Y. Interaction of NaCl and behavioral stress on endogenous sodium pump ligands in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 281 1 (2001) R352-R358
49. Fedorova O.V., Talan M.I., Agalakova N.I., Lakatta E.G., and Bagrov A.Y. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation 105 9 (2002) 1122-1127
50. Fedorova O.V., Kolodkin N.I., Agalakova N.I., Namikas A.R., Bzhelyansky A., St-Louis J., Lakatta E.G., and Bagrov A.Y. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. Journal of Hypertension 23 4 (2005) 835-842
51. Feraille E., and Doucet A. Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiological Reviews 81 1 (2001) 345-418
52. (+)-ATPase: relation to genetic hypertension. The American Journal of Physiology 277 4 Pt 2 (1999) H1338-H1349
53. Ferrandi M., Manunta P., Ferrari P., and Bianchi G. The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications. Frontiers in Bioscience 10 (2005) 2472-2477
54. Fishman M.C. Endogenous digitalis-like activity in mammalian brain. Proceedings of the National Academy of Sciences of the United States of America 76 9 (1979) 4661-4663
55. +-ATPase from mammalian kidneys and Xenopus oocytes by cGMP-dependent protein kinase results in stimulation of ATPase activity. European Journal of Biochemistry/FEBS 260 3 (1999) 904-910
56. Freedman B.D. Mechanisms of calcium signaling and function in lymphocytes. Critical Reviews in Immunology 26 2 (2006) 97-111
57. Frese S., Frese-Schaper M., Andres A.C., Miescher D., Zumkehr B., and Schmid R.A. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Research 66 11 (2006) 5867-5874
58. Fridman A.I., Matveev S.A., Agalakova N.I., Fedorova O.V., Lakatta E.G., and Bagrov A.Y. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity. Journal of Hypertension 20 6 (2002) 1189-1194
59. Garty H., and Karlish S.J. Role of FXYD proteins in ion transport. Annual Review of Physiology 68 (2006) 431-459
60. Geering K. FXYD proteins: new regulators of Na-K-ATPase. American Journal of Physiology. Renal Physiology 290 2 (2006) F241-F250
61. (+)-ATPase and endogenous digitalis-like compounds in depressive disorders. Biological Psychiatry 60 5 (2006) 491-499
62. 2+ signaling. American Journal of Physiology. Cell Physiology 284 2 (2003) C475-C486
63. Gonick H.C., Ding Y., Vaziri N.D., Bagrov A.Y., and Fedorova O.V. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clinical and Experimental Hypertension 20 5-6 (1998) 617-627
64. Goto A., Ishiguro T., Yamada K., Ishii M., Yoshioka M., Eguchi C., Shimora M., and Sugimoto T. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochemical and Biophysical Research Communications 173 3 (1990) 1093-1101
65. Goto A., Yamada K., Ishii M., and Sugimoto T. Digitalis-like activity in human plasma: relation to blood pressure and sodium balance. The American Journal of Medicine 89 4 (1990) 420-426
66. Grider G., El-Mallakh R.S., Huff M.O., Buss T.J., Miller J., and Valdes Jr. R. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. Journal of Affective Disorders 54 3 (1999) 261-267
67. Guengerich F.P. Characterization of human microsomal cytochrome P-450 enzymes. Annual Review of Pharmacology and Toxicology 29 (1989) 241-264
68. Guntert T.W., and Linde H.H.A. Chemistry and structure-activity relationships of cardioactive steroids. In: Greef K. (Ed). Chemistry and Structure-Activity Relationships of Cardioactive Steroids (1981), Springer Verlag, Berlin 13-24
69. +-ATPase. The Journal of Biological Chemistry 275 36 (2000) 27832-27837
70. +-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. The Journal of Biological Chemistry 277 21 (2002) 18694-18702
71. Haddy F.J., and Overbeck H.W. The role of humoral agents in volume expanded hypertension. Life Sciences 19 7 (1976) 935-947
72. Halperin J., Schaeffer R., Galvez L., and Malave S. Ouabain-like activity in human cerebrospinal fluid. Proceedings of the National Academy of Sciences of the United States of America 80 19 (1983) 6101-6104
73. Hamlyn J.M. Biosynthesis of endogenous cardiac glycosides by mammalian adrenocortical cells: three steps forward. Clinical Chemistry 50 3 (2004) 469-470
74. Hamlyn J.M., and Manunta P. Ouabain, digitalis-like factors and hypertension. Journal of Hypertension Supplement 10 7 (1992) S99-S111
75. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Harris D.W., Mandel F., Mathews W.R., and Ludens J.H. Identification and characterization of a ouabain-like compound from human plasma. Proceedings of the National Academy of Sciences of the United States of America 88 14 (1991) 6259-6263
76. Hamlyn J.M., Lu Z.R., Manunta P., Ludens J.H., Kimura K., Shah J.R., Laredo J., Hamilton J.P., Hamilton M.J., and Hamilton B.P. Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clinical and Experimental Hypertension 20 5-6 (1998) 523-533
77. Hamlyn J.M., Laredo J., Shah J.R., Lu Z.R., and Hamilton B.P. 11-Hydroxylation in the biosynthesis of endogenous ouabain: multiple implications. Annals of the New York Academy of Sciences 986 (2003) 685-693
78. Hartwell J.L., and Abbott B.J. Antineoplastic principles in plants: recent developments in the field. Advances in Pharmacology 7 (1969) 117-209
79. +-ATPase with high sodium intake in patients with essential hypertension. Journal of Clinical Hypertension 3 4 (1987) 419-429
80. Haupert Jr. G.T., and Sancho J.M. Sodium transport inhibitor from bovine hypothalamus. Proceedings of the National Academy of Sciences of the United States of America 76 9 (1979) 4658-4660
81. Haux J. Digitoxin is a potential anticancer agent for several types of cancer. Medical Hypotheses 53 6 (1999) 543-548
82. Hilton P.J., White R.W., Lord G.A., Garner G.V., Gordon D.B., Hilton M.J., Forni L.G., McKinnon W., Ismail F.M., Keenan M., Jones K., and Morden W.E. An inhibitor of the sodium pump obtained from human placenta. Lancet 348 9023 (1996) 303-305
83. Huang B.S., and Leenen F.H. Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 34 1 (1999) 107-112
84. Huang Y.T., Chueh S.C., Teng C.M., and Guh J.H. Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells. Biochemical Pharmacology 67 4 (2004) 727-733
85. Huang B.S., Amin M.S., and Leenen F.H. The central role of the brain in salt-sensitive hypertension. Current opinion in cardiology 21 4 (2006) 295-304
86. Ijiri Y., Hayashi T., Kamegai H., Ohi K., Suzuki K., Kitaura Y., and Takenaka H. Digitalis-like immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay. Therapeutic Drug Monitoring 25 2 (2003) 234-239
87. Jing Y., Ohizumi H., Kawazoe N., Hashimoto S., Masuda Y., Nakajo S., Yoshida T., Kuroiwa Y., and Nakaya K. Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Japanese Journal of Cancer Research 85 6 (1994) 645-651
88. Jorgensen P.L., Hakansson K.O., and Karlish S.J. Structure and mechanism of Na,K-ATPase: functional sites and their interactions. Annual Review of Physiology 65 (2003) 817-849
89. + pump alpha subunit isoforms in plasmalemma. Physiological implications. Annals of the New York Academy of Sciences 834 (1997) 524-536
90. Kaide J., Ura N., Torii T., Nakagawa M., Takada T., and Shimamoto K. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats. The American Journal of Hypertension 12 6 (1999) 611-619
91. Kaplan J.H. Biochemistry of Na,K-ATPase. Annual Review of Biochemistry 71 (2002) 511-535
92. Kawamura A., Guo J., Itagaki Y., Bell C., Wang Y., Haupert Jr. G.T., Magil S., Gallagher R.T., Berova N., and Nakanishi K. On the structure of endogenous ouabain. Proceedings of the National Academy of Sciences of the United States of America 96 12 (1999) 6654-6659
93. Kelly R.A., and Smith T.W. Pharmacological treatment of heart failure. In: Herdamn J.G., and Limbird L.E. (Eds). Pharmacological Treatment of Heart Failure (1996), McGraw-Hill comp. 809-838
94. Khundmiri S.J., Metzler M.A., Ameen M., Amin V., Rane M.J., and Delamere N.A. Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells. American Journal of Physiology. Cell Physiology 291 6 (2006) C1247-C1257
95. Kim M., Jung J., Park C.S., and Lee K. Identification of the cofilin-binding sites in the large cytoplasmic domain of Na,K-ATPase. Biochimie 84 10 (2002) 1021-1029
96. Kimelberg H.K., and Mayhew E. Increased ouabain-sensitive 86Rb+ uptake and sodium and potassium ion-activated adenosine triphosphatase activity in transformed cell lines. The Journal of Biological Chemistry 250 1 (1975) 100-104
97. Komiyama Y., Nishimura N., Nishino N., Okuda K., Munakata M., Kosaka C., Masuda M., and Takahashi H. Purification and characterization of ouabain-binding protein in human plasma. Clinical and Experimental Hypertension 20 5-6 (1998) 683-690
98. Komiyama Y., Nishimura N., Munakata M., Mori T., Okuda K., Nishino N., Hirose S., Kosaka C., Masuda M., and Takahashi H. Identification of endogenous ouabain in culture supernatant of PC12 cells. Journal of Hypertension 19 2 (2001) 229-236
99. Komiyama Y., Dong X.H., Nishimura N., Masaki H., Yoshika M., Masuda M., and Takahashi H. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clinical Biochemistry 38 1 (2005) 36-45
100. (+)-ATPase in various cells and tissues. The Journal of Cell Biology 111 6 Pt 1 (1990) 2375-2383
101. Kupzig S., Walker S.A., and Cullen P.J. The frequencies of calcium oscillations are optimized for efficient calcium-mediated activation of Ras and the ERK/MAPK cascade. Proceedings of the National Academy of Sciences of the United States of America 102 21 (2005) 7577-7582
102. Kyosseva S.V. Mitogen-activated protein kinase signaling. International Review of Neurobiology 59 (2004) 201-220
103. Laredo J., Hamilton B.P., and Hamlyn J.M. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 135 2 (1994) 794-797
104. Laredo J., Hamilton B.P., and Hamlyn J.M. Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata. Biochemical and Biophysical Research Communications 212 2 (1995) 487-493
105. Laredo J., Shah J.R., Lu Z.R., Hamilton B.P., and Hamlyn J.M. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 29 1 Pt 2 (1997) 401-407
106. Larre I., Ponce A., Fiorentino R., Shoshani L., Contreras R.G., and Cereijido M. Contacts and cooperation between cells depend on the hormone ouabain. Proceedings of the National Academy of Sciences of the United States of America 103 29 (2006) 10911-10916
107. Leenen F.H., Harmsen E., Yu H., and Yuan B. Dietary sodium stimulates ouabainlike activity in adrenalectomized spontaneously hypertensive rats. The American Journal of Physiology 265 1 Pt 2 (1993) H421-H424
108. Li X., and Stark G.R. NFkappaB-dependent signaling pathways. Experimental Hematology 30 4 (2002) 285-296
109. Li R., el-Mallakh R.S., Harrison L., Changaris D.G., and Levy R.S. Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Molecular and Chemical Neuropathology 31 1 (1997) 65-72
110. Li J., Zelenin S., Aperia A., and Aizman O. Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. Journal of the American Society of Nephrology 17 7 (2006) 1848-1857
111. Liang M., Cai T., Tian J., Qu W., and Xie Z.J. Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. The Journal of Biological Chemistry 281 28 (2006) 19709-19719
112. Liang M., Tian J., Liu L., Pierre S., Liu J., Shapiro J., and Xie Z.J. Identification of a pool of non-pumping Na/K-ATPase. The Journal of Biological Chemistry 282 14 (2007) 10585-10593
113. +-ATPase and heart excitability. In: Sideman S., and Beyar R. (Eds). Advances in Experimental Medicine and Biology (1995), Plenum Press 23-30
114. +-ATPase inhibitors, and brain function. Neurochemical Research 26 8-9 (2001) 971-978
115. Lichtstein D., and Samuelov S. Endogenous 'ouabain like' activity in rat brain. Biochemical and Biophysical Research Communications 96 4 (1980) 1518-1523
116. Lichtstein D., Minc D., Bourrit A., Deutsch J., Karlish S.J., Belmaker H., Rimon R., and Palo J. Evidence for the presence of 'ouabain like' compound in human cerebrospinal fluid. Brain Research 325 1-2 (1985) 13-19
117. Lichtstein D., Gati I., and Ovadia H. Digitalis-like compounds in the toad Bufo viridis: interactions with plasma proteins. Journal of Cardiovascular Pharmacology 22 Suppl 2 (1993) S102-S105
118. Lichtstein D., Gati I., Samuelov S., Berson D., Rozenman Y., Landau L., and Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. European Journal of Biochemistry/FEBS 216 1 (1993) 261-268
119. Lichtstein D., Steinitz M., Gati I., Samuelov S., Deutsch J., and Orly J. Biosynthesis of digitalis-like compounds in rat adrenal cells: hydroxycholesterol as possible precursor. Life Sciences 62 23 (1998) 2109-2126
120. (+)-ATPase. The Journal of Biological Chemistry 269 31 (1994) 19659-19662
121. Liu J. Ouabain-induced endocytosis and signal transduction of the Na/K-ATPase. Frontiers in Bioscience 10 (2005) 2056-2063
122. 2+ concentrations. The Journal of Biological Chemistry 275 36 (2000) 27838-27844
123. Looney S.W., and el-Mallakh R.S. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depression and Anxiety 5 2 (1997) 53-65
124. Manunta P., Rogowski A.C., Hamilton B.P., and Hamlyn J.M. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. Journal of Hypertension 12 5 (1994) 549-560
125. Manunta P., Hamilton J., Rogowski A.C., Hamilton B.P., and Hamlyn J.M. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertension Research 23 Suppl (2000) S77-S85
126. Manunta P., Messaggio E., Ballabeni C., Sciarrone M.T., Lanzani C., Ferrandi M., Hamlyn J.M., Cusi D., Galletti F., and Bianchi G. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 38 2 (2001) 198-203
127. Manunta P., Hamilton B.P., and Hamlyn J.M. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 290 3 (2006) R553-R559
128. Martin P.E., Hill N.S., Kristensen B., Errington R.J., and Rachael J.T. Ouabain exerts biphasic effects on connexin functionality and expression in vascular smooth muscle cells. British Journal of Pharmacology 141 2 (2004) 374-384
129. Masugi F., Ogihara T., Hasegawa T., Tomii A., Nagano M., Higashimori K., Kumahara K., and Terano Y. Circulating factor with ouabain-like immunoreactivity in patients with primary aldosteronism. Biochemical and Biophysical Research Communications 135 1 (1986) 41-45
130. Masugi F., Ogihara T., Hasegawa T., Sakaguchi K., and Kumahara Y. Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma. Journal of Human Hypertension 2 1 (1988) 17-20
131. Mathews W.R., DuCharme D.W., Hamlyn J.M., Harris D.W., Mandel F., Clark M.A., and Ludens J.H. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 17 6 Pt 2 (1991) 930-935
132. +-ATPase inhibitors down-regulate gene expression of the intracellular signaling protein 14-3-3 in rat lens. The Journal of Pharmacology and Experimental Therapeutics 289 3 (1999) 1559-1563
133. Mellon S.H., Griffin L.D., and Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Research 37 1-3 (2001) 3-12
134. Mellon S.H., and Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. International Review of Neurobiology 46 (2001) 33-78
135. Meyer K., and Linde H. Collection of toad venoms and chemistry of the toad venom steroids. In: Bucherl W., and Buckley E.E. (Eds). Collection of Toad Venoms and Chemistry of the Toad Venom Steroids (1971), Academic Press, New York
136. Miller W.L. Early steps in androgen biosynthesis: from cholesterol to DHEA. Bailliere's Clinical Endocrinology and Metabolism 12 1 (1998) 67-81
137. Miyakawa-Naito A., Uhlen P., Lal M., Aizman O., Mikoshiba K., Brismar H., Zelenin S., and Aperia A. Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. The Journal of Biological Chemistry 278 50 (2003) 50355-50361
138. +-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Bioscience Reports 20 2 (2000) 51-91
139. Mobasheri A., Fox R., Evans I., Cullingham F., Martin-Vasallo P., and Foster C.S. Epithelial Na, K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy. Cancer Cell International 3 1 (2003) 8
140. (+)-ATPase activity in toad brain. Comparative biochemistry and physiology 118 3 (1997) 599-606
141. (+)-ATPase alpha(1)beta(1), alpha(2)beta(1), and alpha(3)beta(1) when expressed separately in yeast cells. American Journal of Physiology. Cell Physiology 281 4 (2001) C1355-C1364
142. Naruse K., Naruse M., Tanabe A., Yoshimoto T., Watanabe Y., Kurimoto F., Horiba N., Tamura M., Inagami T., and Demura H. Does plasma immunoreactive ouabain originate from the adrenal gland?. Hypertension 23 1 Suppl (1994) I102-I105
143. +)ATPase and implications for the organization of membrane domains in polarized cells. Nature 328 6130 (1987) 533-536
144. Nguyen A.N., Wallace D.P., and Blanco G. Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation. Journal of the American Society of Nephrology 18 1 (2007) 46-57
145. (+)-ATPase inhibition in K562 cell differentiation induced by bufalin. Journal of Cellular Physiology 160 1 (1994) 113-120
146. +]i. Pflügers Archiv: European Journal of Physiology 448 3 (2004) 335-345
147. Pasdois P., Quinlan C.L., Rissa A., Tariosse L., Vinassa B., Costa A.D., Pierre S., Dos Santos P., and Garlid K.D. Ouabain protects rat hearts against ischemia-reperfusion injury via a pathway involving src kinase, mitoKATP, and ROS. American Journal of Physiology. Heart and Circulatory Physiology 292 3 (2007) H1470-H1478
148. Pauli-Magnus C., Murdter T., Godel A., Mettang T., Eichelbaum M., Klotz U., and Fromm M.F. P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin. Naunyn-Schmiedeberg's Archives of Pharmacology 363 3 (2001) 337-343
149. Peck T.W., and Wilkinson K.D. William Withering of Birmingham (1950), John Wright and Sons, Birmingham, U.K.
150. Periyasamy S.M., Liu J., Tanta F., Kabak B., Wakefield B., Malhotra D., Kennedy D.J., Nadoor A., Fedorova O.V., Gunning W., Xie Z., Bagrov A.Y., and Shapiro J.I. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney International 67 5 (2005) 1868-1877
151. Perrin A., Brasmes B., Chambaz E.M., and Defaye G. Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Molecular and Cellular Endocrinology 126 1 (1997) 7-15
152. Pierdomenico S.D., Bucci A., Manunta P., Rivera R., Ferrandi M., Hamlyn J.M., Lapenna D., Cuccurullo F., and Mezzetti A. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. American Journal of Hypertension 14 1 (2001) 44-50
153. +-ATPase signaling cascade in rat hearts. Cardiovascular Research 73 3 (2007) 488-496
154. Pressley T.A. Structure and function of the Na,K pump: ten years of molecular biology. Mineral and Electrolyte Metabolism 22 5-6 (1996) 264-271
155. Qazzaz H.M., Cao Z., Bolanowski D.D., Clark B.J., and Valdes Jr. R. De novo biosynthesis and radiolabeling of mammalian digitalis-like factors. Clinical Chemistry 50 3 (2004) 612-620
156. Rajasekaran A.K., and Rajasekaran S.A. Role of Na-K-ATPase in the assembly of tight junctions. American Journal of Physiology. Renal Physiology 285 3 (2003) F388-F396
157. Rajasekaran S.A., Ball Jr. W.J., Bander N.H., Liu H., Pardee J.D., and Rajasekaran A.K. Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. The Journal of Urology 162 2 (1999) 574-580
158. Ringer S. Regarding the influence of the organic constituents of the blood on the contractility of the ventricle. The Journal of Physiology 6 6 (1885) 361-463 367
159. Robel P., and Baulieu E.E. Neurosteroids: biosynthesis and function. Critical Reviews in Neurobiology 9 4 (1995) 383-394
160. Roden D.M. Antiarrhythmic drugs. In: Hardman J.G., Limbird L.E., Molinoff P.B., and Ruddon R.W. (Eds). Antiarrhythmic Drugs (1996), McGraw-Hill, NY 839-874
161. Rosen H., Glukhman V., Feldmann T., Fridman E., and Lichtstein D. Cardiac steroids induce changes in recycling of the plasma membrane in human NT2 cells. Molecular Biology of the Cell 15 3 (2004) 1044-1054
162. Rossi G., Manunta P., Hamlyn J.M., Pavan E., De Toni R., Semplicini A., and Pessina A.C. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. Journal of Hypertension 13 10 (1995) 1181-1191
163. Ruktanonchai D.J., El-Mallakh R.S., Li R., and Levy R.S. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiology & Behavior 63 3 (1998) 403-406
164. Rupprecht R., and Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosciences 22 9 (1999) 410-416
165. (+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Letters 563 1-3 (2004) 151-154
166. Saunders R., and Scheiner-Bobis G. Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump. European Journal of Biochemistry/FEBS 271 5 (2004) 1054-1062
167. Scheiner-Bobis G., and Schoner W. A fresh facet for ouabain action. Nature Medicine 7 12 (2001) 1288-1289
168. Schneider R., Antolovic R., Kost H., Sich B., Kirch U., Tepel M., Zidek W., and Schoner W. Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure. Clinical and Experimental Hypertension 20 5-6 (1998) 593-599
169. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. European Journal of Biochemistry/FEBS 269 10 (2002) 2440-2448
170. Schoner W., Bauer N., Muller-Ehmsen J., Kramer U., Hambarchian N., Schwinger R., Moeller H., Kost H., Weitkamp C., Schweitzer T., Kirch U., Neu H., and Grunbaum E.G. Ouabain as a mammalian hormone. Annals of the New York Academy of Sciences 986 (2003) 678-684
171. Shah J.R., Laredo J., Hamilton B.P., and Hamlyn J.M. Different signaling pathways mediate stimulated secretions of endogenous ouabain and aldosterone from bovine adrenocortical cells. Hypertension 31 1 Pt 2 (1998) 463-468
172. (+) pump alpha 2-isoform specifically couples to contractility in vascular smooth muscle: evidence from gene-targeted neonatal mice. American Journal of Physiology. Cell Physiology 286 4 (2004) C813-C820
173. Shen S.S., Hamamoto S.T., Bern H.A., and Steinhardt R.A. Alteration of sodium transport in mouse mammary epithelium associated with neoplastic transformation. Cancer Research 38 5 (1978) 1356-1361
174. Shiratori O. Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: in vitro and in vivo studies. Gan Gann; The Japanese Journal of Cancer Research 58 6 (1967) 521-528
175. Sirover M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochimica et Biophysica Acta 1432 2 (1999) 159-184
176. Sirover M.A. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. Journal of Cellular Biochemistry 95 1 (2005) 45-52
177. Sophocleous A., Elmatzoglou I., and Souvatzoglou A. Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent. Journal of Endocrinological Investigation 26 7 (2003) 668-674
178. Stenkvist B. Is digitalis a therapy for breast carcinoma?. Oncology Reports 6 3 (1999) 493-496
179. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annual Review of Physiology 63 (2001) 193-213
180. Szent-Gyorgyi A. Chemical physiology of contraction. Body and Heart Muscle (1953), Academic Press, New York 86-91
181. Taurin S., Dulin N.O., Pchejetski D., Grygorczyk R., Tremblay J., Hamet P., and Orlov S.N. c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism. The Journal of Physiology 543 Pt 3 (2002) 835-847
182. Terness P., Navolan D., Dufter C., Kopp B., and Opelz G. The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. International Immunopharmacology 1 1 (2001) 119-134
183. Therien A.G., and Blostein R. Mechanisms of sodium pump regulation. American Journal of Physiology. Cell Physiology 297 3 (2000) C541-C566
184. +-ATPase forms a functional signaling complex. Molecular Biology of the Cell 17 1 (2006) 317-326
185. +-ATPase inhibition. Journal of Basic and Clinical Physiology and Pharmacology 11 4 (2000) 375-394
186. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual Review of Pharmacology and Toxicology 40 (2000) 581-616
187. Vallee M., Mayo W., and Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Research 37 1-3 (2001) 301-312
188. Veerasingham S.J., and Leenen F.H. Excitotoxic lesions of the ventral anteroventral third ventricle and pressor responses to central sodium, ouabain and angiotensin II. Brain Research 749 1 (1997) 157-160
189. Veerasingham S.J., and Leenen F.H. Ouabain- and central sodium-induced hypertension depend on the ventral anteroventral third ventricle region. The American Journal of Physiology 276 1 Pt 2 (1999) H63-H70
190. +-ATPase. The Journal of Biological Chemistry 279 17 (2004) 17250-17259
191. Watabe M., Kawazoe N., Masuda Y., Nakajo S., and Nakaya K. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells. Cancer Research 57 15 (1997) 3097-3100
192. Weidemann H. Na/K-ATPase, endogenous digitalis like compounds and cancer development - a hypothesis. Frontiers in Bioscience 10 (2005) 2165-2176
193. Weidemann H., Salomon N., Avnit-Sagi T., Weidenfeld J., Rosen H., and Lichtstein D. Diverse effects of stress and additional adrenocorticotropic hormone on digitalis-like compounds in normal and nude mice. Journal of Neuroendocrinology 16 5 (2004) 458-463
194. (+)-ATPase as a signal transducer. European Journal of Biochemistry/FEBS 269 10 (2002) 2434-2439
195. +-ATPase-mediated signal transduction: from protein interaction to cellular function. Molecular Interventions 3 3 (2003) 157-168
196. Xie Z., and Xie J. The Na/K-ATPase-mediated signal transduction as a target for new drug development. Frontiers in Bioscience 10 (2005) 3100-3109
197. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. The Journal of Biological Chemistry 274 27 (1999) 19323-19328
198. Yamada K., Goto A., and Omata M. Adrenocorticotropin-induced hypertension in rats: role of ouabain-like compound. American Journal of Hypertension 10 4 Pt 1 (1997) 403-408
199. Yang Q., Huang W., Jozwik C., Lin Y., Glasman M., Caohuy H., Srivastava M., Esposito D., Gillette W., Hartley J., and Pollard H.B. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proceedings of the National Academy of Sciences of the United States of America 102 27 (2005) 9631-9636
200. You L. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. Chemico-Biological Interactions 147 3 (2004) 233-246
201. Yuan C.M., Manunta P., Hamlyn J.M., Chen S., Bohen E., Yeun J., Haddy F.J., and Pamnani M.B. Long-term ouabain administration produces hypertension in rats. Hypertension 22 2 (1993) 178-187
202. Yuan Z., Cai T., Tian J., Ivanov A.V., Giovannucci D.R., and Xie Z. Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Molecular Biology of the Cell 16 9 (2005) 4034-4045
203. +-ATPase alpha subunit and regulates its trafficking. Proceedings of the National Academy of Sciences of the United States of America 97 12 (2000) 6556-6561
204. Zhang L., Nakaya K., Yoshida T., and Kuroiwa Y. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Research 52 17 (1992) 4634-4641
205. Zhang S., Malmersjo S., Li J., Ando H., Aizman O., Uhlen P., Mikoshiba K., and Aperia A. Distinct role of the N-terminal tail of the Na,K-ATPase catalytic subunit as a signal transducer. The Journal of Biological Chemistry 281 31 (2006) 21954-21962